We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Gold Nanoparticles Indicate Early Detection of Heart Attacks

By LabMedica International staff writers
Posted on 27 Jan 2015
Print article
Image: Microscopic view of microplasma-gold nanoparticles on a new, highly sensitive test strip that enables early detection of heart attacks (Photo courtesy of New York University Polytechnic School of Engineering).
Image: Microscopic view of microplasma-gold nanoparticles on a new, highly sensitive test strip that enables early detection of heart attacks (Photo courtesy of New York University Polytechnic School of Engineering).
A test strip for a heart attack biomarker is being developed as its level is several thousand times higher in patients experiencing myocardial infarctions. The new strip uses microplasma technology.

Cardiac troponin I (cTn-I) is a specific marker for myocardial infarction and a new cTn-I test is based on the specific immune-chemical reactions between antigen and antibody on immunochromatographic test strips using gold nanoparticles (AuNPs).

Bioengineers at the New York University Polytechnic School of Engineering used an atmospheric-pressure non-thermal microplasma for the synthesis of aqueous gold nanoparticles (AuNPs). The microplasma-induced liquid chemistry was analyzed by monitoring the pH value and the conductivity of the liquid. A sample pad made of glass fiber was saturated with 100 mM phosphate buffered saline and the anti-cardiac troponin antibody19C7 MAb (HyTest Ltd.; Turku, Finland) was conjugated to AuNPs and sprayed onto the conjugate pad. After the addition of other antibodies, the nitrocellulose membranes were combined with the conjugate pad at the opposite end downstream of the control line. The sample pad was placed on top and in front of the conjugate pad at the site of the sample application wells.

Compared to AuNPs produced by traditional chemical methods, the surfaces of the gold nanoparticles generated by the microplasma-induced liquid chemical process attracted more antibodies, which resulted in significantly higher detection sensitivity. A positive result yields reddish bands at both the test (T) and control (C) positions, whereas a negative result yields a reddish band at position C only. The level of cTn-I is below 0.06 ng/mL in the blood of healthy people, whereas the level of cTn-I may reach 100 ng/mL to 1,300 ng/mL in patients after the onset of acute myocardial infarction (AMI) and remains high for up to four to10 days.

The authors concluded that the immune-chromatography test assays for cTn-I prepared by AuNPs generated by plasma-liquid interaction exhibit higher detection sensitivity than those prepared by chemically reduced AuNPs detection. They believe that the microplasma-assisted synthesis of AuNPs have great potential for a variety of biomedical and therapeutic applications. The study was first published online on December 11, 2014, in the journal Plasma Processes and Polymers.

Related Links:

New York University Polytechnic School of Engineering
HyTest Ltd. 


Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
One Step HbA1c Measuring System
GREENCARE A1c
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Magnetic Bead Separation Modules
MAG and HEATMAG

Print article

Channels

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.